Catalyst Wire Dossier Catalyst Wire Dossier

Investigational drug (NCT00105157)

· Merck Sharp & Dohme LLC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Investigational drug (NCT00105157), covering 2010-04-12 to 2010-04-12. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of an Investigational Drug in Human Immunodeficiency Virus (HIV)-Infected Patients Failing Current Antiretroviral Therapies (0518-005)(COMPLETED) [Phase 2]

See pricing